Literature DB >> 10521487

Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B.

L Bertrand1, D R Alessi, J Deprez, M Deak, E Viaene, M H Rider, L Hue.   

Abstract

Previous studies have shown that (i) the insulin-induced activation of heart 6-phosphofructo-2-kinase (PFK-2) is wortmannin-sensitive, but is insensitive to rapamycin, suggesting the involvement of phosphatidylinositol 3-kinase; and (ii) protein kinase B (PKB) activates PFK-2 in vitro by phosphorylating Ser-466 and Ser-483. In this work, we have studied the effects of phosphorylation of these residues on PFK-2 activity by replacing each or both residues with glutamate. Mutation of Ser-466 increased the V(max) of PFK-2, whereas mutation of Ser-483 decreased citrate inhibition. Mutation of both residues was required to decrease the K(m) for fructose 6-phosphate. We also studied the insulin-induced activation of heart PFK-2 in transfection experiments performed in human embryonic kidney 293 cells. Insulin activated transfected PFK-2 by phosphorylating Ser-466 and Ser-483. Kinase-dead (KD) PKB and KD 3-phosphoinositide-dependent kinase-1 (PDK-1) cotransfectants acted as dominant negatives because both prevented the insulin-induced activation of PKB as well as the inactivation of glycogen-synthase kinase-3, an established substrate of PKB. However, the insulin-induced activation of PFK-2 was prevented only by KD PDK-1, but not by KD PKB. These results indicate that the insulin-induced activation of heart PFK-2 is mediated by a PDK-1-activated protein kinase other than PKB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521487     DOI: 10.1074/jbc.274.43.30927

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer.

Authors:  V Stoll; V Calleja; G Vassaux; J Downward; N R Lemoine
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 3.  Metabolism and immunity in breast cancer.

Authors:  Deyu Zhang; Xiaojie Xu; Qinong Ye
Journal:  Front Med       Date:  2020-10-19       Impact factor: 4.592

4.  Kinetics of regulatory serine variants of tyrosine hydroxylase with cyclic AMP-dependent protein kinase and extracellular signal-regulated protein kinase 2.

Authors:  Montserrat Royo; S Colette Daubner
Journal:  Biochim Biophys Acta       Date:  2006-02-14

5.  Partial purification and characterization of a wortmannin-sensitive and insulin-stimulated protein kinase that activates heart 6-phosphofructo-2-kinase.

Authors:  J Deprez; L Bertrand; D R Alessi; U Krause; L Hue; M H Rider
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

6.  Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate.

Authors:  Fa-Xing Yu; Tin Fan Chai; Hongpeng He; Thilo Hagen; Yan Luo
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

Review 7.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

8.  14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase.

Authors:  Mercedes Pozuelo Rubio; Mark Peggie; Barry H C Wong; Nick Morrice; Carol MacKintosh
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

Review 9.  Dual-Specific Protein and Lipid Phosphatase PTEN and Its Biological Functions.

Authors:  Taojian Tu; Jingyu Chen; Lulu Chen; Bangyan L Stiles
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 6.915

10.  Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia.

Authors:  Alfonso Mora; Anthony M Davies; Luc Bertrand; Isam Sharif; Grant R Budas; Sofija Jovanović; Véronique Mouton; C Ronald Kahn; John M Lucocq; Gillian A Gray; Aleksandar Jovanović; Dario R Alessi
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.